China Resources Pharmaceutical Group Limited logo

China Resources Pharmaceutical Group Limited (640)

Market Closed
11 Aug, 11:06
XDUS XDUS
0. 52
0
0%
- Market Cap
- P/E Ratio
0.36% Div Yield
0 Volume
- Eps
0.52
Previous Close
Add Transaction
Day Range
0.52 0.53
Year Range
0.46 0.69
Want to track 640 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

640 closed today higher at €0.52, an increase of 0% from yesterday's close, completing a monthly increase of 13.6364% or €0.06. Over the past 12 months, 640 stock gained 9.8326%.
640 pays dividends to its shareholders, with the most recent payment made on Jul 21, 2026. The next estimated payment will be in In 5 months on Jan 21, 2027 for a total of €0.139.
The last earnings report, released on Mar 24, 2026, missed the consensus estimates by -0.2226%. On average, the company has fell short of earnings expectations by -0.1113%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on HKEX (HKD).

640 Chart

China Resources Pharmaceutical Group Limited (640) FAQ

What is the stock price today?

The current price is €0.52.

On which exchange is it traded?

China Resources Pharmaceutical Group Limited is listed on XDUS.

What is its stock symbol?

The ticker symbol is 640.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.36%.

What is its market cap?

As of today, no market cap data is available.

Has China Resources Pharmaceutical Group Limited ever had a stock split?

No, there has never been a stock split.

China Resources Pharmaceutical Group Limited Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Xiaosong Bai CEO
XDUS Exchange
HK0000311099 ISIN
Hong Kong Country
72,764 Employees
3 Jun 2026 Last Dividend
- Last Split
- IPO Date

Overview

China Resources Pharmaceutical Group Limited, a significant player in the healthcare and pharmaceutical sectors, incorporates a comprehensive approach to its business by engaging in the research, development, manufacture, distribution, and retail of pharmaceutical and other healthcare products. Primarily operating in Mainland China and Hong Kong, the company functions through four main segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. Originally known as China Resources Medications Group Limited, it rebranded to its current name in December 2011. Established in 2007 and headquartered in Wan Chai, Hong Kong, this subsidiary of CRH (Pharmaceutical) Limited has a broad operational scope, catering to various healthcare needs through its extensive product portfolio and services. It distinguishes itself through a potent mix of manufacturing, comprehensive distribution network, and retail capabilities, all aimed at improving healthcare accessibility and efficiency.

Products and Services

The company's offerings span across a wide array of healthcare needs, ensuring a comprehensive approach to wellbeing and medical care:

  • Chemical Drugs: These encompass a broad range of medication designed to address various health conditions, leveraging chemical science for therapeutic benefits.
  • Chinese Medicines: Traditional Chinese medicines are offered, tapping into centuries-old practices and natural remedies for health and wellness.
  • Biopharmaceutical Drugs: Focusing on biologically based treatments, these drugs represent the cutting-edge of therapeutic innovation, targeting a wide range of illnesses with precision medicine.
  • Nutritional and Healthcare Products: A variety of products aimed at promoting general health, addressing nutritional deficiencies, and supporting disease prevention efforts.
  • Pharmaceutical Manufacturing: The segment involves the production of a diverse drug portfolio, ensuring high-quality manufacturing practices and compliance with global standards.
  • Pharmaceutical Distribution: This includes warehousing, logistics, and other pharmaceutical supply chain solutions, aimed at efficiently distributing products to hospitals, distributors, and pharmacies.
  • Pharmaceutical Retail: With retail pharmacies operating under the CR Care and Teck Soon Hong brands, this segment ensures direct access to medicines and healthcare products for consumers.
  • Other Services: In addition to its core offerings, the company engages in property holding activities and provides value-added services related to the pharmaceutical supply chain to enhance the overall efficiency and effectiveness of healthcare product distribution.

Contact Information

Address: China Resources Building
Phone: 852 2593 8991